Treatment With Tumour Necrosis Factor Inhibitor Oxpentifylline Does Not Improve Corticosteroid Dependent Chronic Active Crohn's Disease.

Gut - United Kingdom
doi 10.1136/gut.40.4.470
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Secondary Amyloidosis in Crohn's Disease: Treatment With Tumour Necrosis Factor Inhibitor

Gut
Gastroenterology
2006English

Tumour Necrosis Factor (TNF ) as a Novel Therapeutic Target in Symptomatic Corticosteroid Dependent Asthma

Thorax
PulmonaryRespiratory Medicine
2005English

Chronic Recurrent Multifocal Osteomyelitis: Treatment With a Tumor Necrosis Factor-Alpha Inhibitor

Turkish Journal of Rheumatology
2013English

Giant Cell Myocarditis in a Patient With Crohn's Disease, Treated With Etanercept – A Tumour Necrosis Factor-Alpha Antagonist

Canadian Journal of Gastroenterology
2001English

Immunohistochemical Studies of Intrahepatic Tumour Necrosis Factor Alpha in Chronic Liver Disease.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1990English

Association of Tumour Necrosis Factor Promoter Haplotype With Chronic Pancreatitis

Gut
Gastroenterology
2006English

NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in Chronic Kidney Disease

Kidney International Reports
Nephrology
2018English

Increased Epithelial Uptake of Protein Antigens in the Ileum of Crohn's Disease Mediated by Tumour Necrosis Factor

Gut
Gastroenterology
2004English

Tumour Necrosis Factor-Alpha Production in Human Alveolar Macrophages: Modulation by Inhaled Corticosteroid

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy